Mike Heijmans

This site is built using Next.js, Motion, and Mantine running on Vercel. The source code is available on GitHub.

© 2026 Michael Heijmans

U.S. Federal Register Tool

From Presidential Orders to Rule Proposals by various agencies, this tool helps you keep track of the documents as they are published to the Federal Register to keep up with what's happening on Capital Hill.

Results per page:

Showing 10 of 10000 documents

Showing 10 of 10000 documents

Medicaid Program; Community Engagement Requirement for Certain Individuals

Type: Rule

Doc Number: C1-2026-11094

Published: 2026-06-29

Agencies:

Health and Human Services Department
Centers for Medicare & Medicaid Services

Real Estate Lending Escrow Accounts

Type: Rule

Doc Number: C1-2026-10036

Published: 2026-06-29

Agencies:

Treasury Department
Comptroller of the Currency

Sunshine Act Meetings: Notice of Meeting Held With Less Than Seven Days' Advance Notice

Type: Notice

Doc Number: 2026-13116

Published: 2026-06-29

Agencies:

Federal Deposit Insurance Corporation

Sunshine Act Meetings

Type: Notice

Doc Number: 2026-13115

Published: 2026-06-29

Agencies:

Federal Deposit Insurance Corporation

Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock Absorber

Type: Rule

Doc Number: 2026-13101

Published: 2026-06-29

Agencies:

Health and Human Services Department
Food and Drug Administration

The Food and Drug Administration (FDA) is classifying the medial knee implanted shock absorber into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the medial knee implanted shock absorber. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.

Cellular, Tissue, and Gene Therapies Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Biologics License Application (BLA) 125842 From Capricor, Inc. for Deramiocel (Human Allogeneic Cardiosphere-Derived Cells)

Type: Notice

Doc Number: 2026-13096

Published: 2026-06-29

Agencies:

Health and Human Services Department
Food and Drug Administration

The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Cellular, Tissue, and Gene Therapies Advisory Committee (the Committee). The general function of the Committee is to provide advice and recommendations to FDA on regulatory issues. The meeting will be open to the public. FDA is establishing a docket for public comment on this document.

Notice of Public Comments on Section 133 of the Expanding Public Lands Outdoor Recreation Experiences (EXPLORE) Act

Type: Notice

Doc Number: 2026-13095

Published: 2026-06-29

Agencies:

Agriculture Department
Forest Service

Section 133 of the Expanding Public Lands Outdoor Recreation Experiences (EXPLORE) Act requires the Secretaries, after public notice and comment, to establish pilot protocols at not fewer than 10 land management units under the jurisdiction of each Secretary to model recreation use patterns, including low-use recreation activities and dispersed recreation activities, that may not be effectively measured by existing general and opportunistic survey and monitoring protocols. Through this notice, the agencies request public comment on the proposed pilot protocols and proposed land management units identified for those pilots.

Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Survey of Postgraduate Employment for the Foreign Language and Area Studies (FLAS) Fellowship Program

Type: Notice

Doc Number: 2026-13094

Published: 2026-06-29

Agencies:

Education Department

In accordance with the Paperwork Reduction Act (PRA) of 1995, the Department is proposing revision of a currently approved information collection request (ICR).

Center for Scientific Review; Notice of Closed Meetings

Type: Notice

Doc Number: 2026-13093

Published: 2026-06-29

Agencies:

Health and Human Services Department
National Institutes of Health

Technical Guidelines for the Production of Regenerative Agricultural Biofuel Feedstocks

Type: Rule

Doc Number: 2026-13092

Published: 2026-06-29

Agencies:

Agriculture Department
Energy and Environmental Policy Office

This final rule revises technical guidelines for quantifying, reporting, and verifying the carbon intensity of agricultural commodity crops used in the production of biofuels relative to an estimated national average that were established by a prior January 2025 interim rule. Specifically, the January 2025 interim rule established guidelines for the implementation, reporting, verification, and quantification of carbon intensity (CI) of certain agricultural commodities at the field-scale. This final rule makes revisions to the January 2025 interim rule that were requested by commenters or that are otherwise necessary because of intervening Executive action. The revised guidelines articulate an approach for farm producers to quantify the change in net emissions associated with crops produced using one or more authorized practices. The revised guidelines also articulate a framework for how information regarding emissions, resulting from the production of biofuel feedstock commodity crops, could be reported and tracked throughout the supply chain.

Results per page:

Powered by the Federal Register API